Form 8-K - Current report:
SEC Accession No. 0001640334-25-002348
Filing Date
2025-12-16
Accepted
2025-12-16 16:05:36
Documents
22
Period of Report
2025-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 41912
2 COMMON STOCK PURCHASE WARRANT lxrp_ex41.htm EX-4.1 95443
3 PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT lxrp_ex42.htm EX-4.2 96647
4 OPINION lxrp_ex51.htm EX-5.1 13932
5 SECURITIES PURCHASE AGREEMENT lxrp_ex101.htm EX-10.1 222048
6 PRESS RELEASE lxrp_ex991.htm EX-99.1 12048
7 PRESS RELEASE lxrp_ex992.htm EX-99.2 10137
13 lxrp_ex51img6.jpg GRAPHIC 7096
14 lxrp_ex51img5.jpg GRAPHIC 7096
  Complete submission text file 0001640334-25-002348.txt   775607

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20251214.xsd EX-101.SCH 5417
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20251214_lab.xml EX-101.LAB 16213
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20251214_cal.xml EX-101.CAL 898
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20251214_pre.xml EX-101.PRE 11893
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20251214_def.xml EX-101.DEF 5708
24 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5577
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 251575221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)